share_log

方盛制药(603998.SH):上半年净利润1.37亿元 同比增长28.23%

Hunan Fangsheng Pharmaceutical (603998.SH): Net income in the first half of the year was 0.137 billion yuan, a year-on-year increase of 28.23%.

Gelonghui Finance ·  Aug 28 08:04

Hunan Fangsheng Pharmaceutical (603998.SH) announced its semi-annual report on August 28. During the reporting period, the company achieved revenue of 0.91 billion yuan, an increase of 6.44% year-on-year. The net income attributable to shareholders of the listed company was 0.137 billion yuan, a year-on-year increase of 28.23%. Among them, the pharmaceutical manufacturing business achieved operating income of 837.1133 million yuan, a year-on-year increase of 9.12%. A cash dividend of 0.50 yuan per 10 shares was distributed to all shareholders registered on the equity registration day.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment